Plainsboro, NJ, United States of America

Anran Li

This inventor holds 1 USPTO granted patent. Top assignee: Princeton University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anran Li. Retrieved from https://idiyas.com/inventor/anran-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anran Li: Innovator in Anti-Virulence Research

Introduction

Anran Li is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of anti-virulence agents. His innovative approach to utilizing existing compounds for new therapeutic applications showcases his dedication to advancing healthcare solutions.

Latest Patents

Anran Li holds a patent for his work titled "Guanfacine as an anti-virulence agent." This patent discloses methods for using guanfacine, an analog or derivative of guanfacine, or a pharmaceutically acceptable salt thereof, to reduce the virulence of bacterial pathogens. The method generally involves administering a therapeutically effective dose of guanfacine to a patient. An alternative method includes contacting the bacterial pathogen directly with guanfacine or its derivatives. He has 1 patent to his name.

Career Highlights

Anran Li is affiliated with Princeton University, where he continues to engage in groundbreaking research. His work not only contributes to academic knowledge but also has practical implications for treating bacterial infections.

Collaborations

Anran Li collaborates with esteemed colleagues, including Mohammad R Seyedsayamdost and Bethany K Okada, who bring diverse expertise to their research endeavors.

Conclusion

Anran Li's innovative research in anti-virulence agents exemplifies the potential of existing medications to combat bacterial infections. His contributions to the field are invaluable and highlight the importance of continued research in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…